Compare VTR & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTR | HLN |
|---|---|---|
| Founded | 1983 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Package Goods/Cosmetics |
| Sector | Real Estate | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.2B | 41.7B |
| IPO Year | 1998 | N/A |
| Metric | VTR | HLN |
|---|---|---|
| Price | $80.81 | $9.77 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 1 |
| Target Price | ★ $77.92 | N/A |
| AVG Volume (30 Days) | 3.2M | ★ 9.0M |
| Earning Date | 10-29-2025 | 07-31-2025 |
| Dividend Yield | ★ 2.38% | 1.85% |
| EPS Growth | N/A | ★ 41.64 |
| EPS | ★ 0.53 | 0.23 |
| Revenue | $5,544,046,000.00 | ★ $15,096,588,575.00 |
| Revenue This Year | $16.61 | $1.41 |
| Revenue Next Year | $9.31 | $4.52 |
| P/E Ratio | $152.84 | ★ $20.97 |
| Revenue Growth | ★ 16.38 | N/A |
| 52 Week Low | $56.68 | $8.71 |
| 52 Week High | $80.99 | $11.42 |
| Indicator | VTR | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 77.34 | 57.18 |
| Support Level | $78.39 | $9.65 |
| Resistance Level | $80.50 | $9.84 |
| Average True Range (ATR) | 1.00 | 0.12 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 95.75 | 62.04 |
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.